<p>Maximus, Inc.（纽约证券交易所代码：MMS - 获取免费报告）首席财务官 David Mutryn 于 2 月 9 日星期一购买了 1,000 股该股票。该股票的平均购买成本为每股 75.62 美元，总交易额为 75,620.00 美元。收购完成后，首席财务官在公司中持有 40,037 股，价值为 3,027,597.94 美元。这代表其持股增加了 2.56%。此次购买在向美国证券交易委员会（SEC）提交的文件中披露，相关信息可通过 SEC 网站访问。</p>
<h2>Maximus 价格表现</h2>
<p>在周一的午盘交易中，MMS 的股价上涨了 0.01 美元，达到了 75.09 美元。该公司交易了 1,168,871 股，而其平均交易量为 674,064 股。该股票的市值为 41 亿美元，市盈率为 11.43，贝塔值为 0.56。该公司 50 日移动平均线为 90.07 美元，200 日移动平均线为 86.58 美元。公司的债务与股本比率为 0.88，速动比率为 2.34，流动比率为 2.34。Maximus, Inc.的 52 周低点为 63.77 美元，52 周高点为 100.00 美元。</p>
<p>Maximus（纽约证券交易所代码：MMS - 获取免费报告）最近一次发布财报是在 2 月 5 日星期四。这家健康服务提供商报告本季度每股收益为 1.85 美元，超出分析师一致预期的 1.84 美元，超出幅度为 0.01 美元。Maximus 的净利润率为 6.92%，股本回报率为 25.30%。该公司本季度的收入为 13.5 亿美元，而分析师预期为 13.7 亿美元。去年同期，该公司每股收益为 1.61 美元。与去年同期相比，Maximus 本季度的收入下降了 4.1%。Maximus 已将其 2026 财年的指引设定为每股收益 8.050-8.350 美元。分析师平均预测 Maximus, Inc.在当前财年将发布每股收益 6.15 美元。</p>
<h2>Maximus 增加股息</h2>
<p>该公司最近还披露了一项季度股息，将于 3 月 2 日星期一支付。2 月 13 日星期五的股东将获得 0.33 美元的股息。这比 Maximus 之前的季度股息 0.30 美元有所增加。该股息的除息日期为 2 月 13 日星期五。这代表每年 1.32 美元的股息，收益率为 1.8%。Maximus 的股息支付比率目前为 18.26%。</p>
<h2>分析师评级变动</h2>
<p>MMS 成为多份研究报告的主题。Zacks Research 在 12 月 30 日星期二的研究报告中将 Maximus 的评级从 “持有” 上调至 “强力买入”。Wall Street Zen 在周六的报告中将 Maximus 的评级从 “买入” 下调至 “持有”。最后，Weiss Ratings 在 12 月 29 日星期一的研究报告中重申了对 Maximus 的 “买入（b-）” 评级。一位股票研究分析师对该股票给予了 “强力买入” 评级，另一位则给予了 “买入” 评级。根据 MarketBeat.com 的数据，该股票的平均评级为 “强力买入”。</p>
<p><strong>阅读我们对 Maximus 的最新分析</strong></p>
<h2>机构资金流入和流出</h2>
<p>对该股票的对冲基金最近进行了买卖。Dimensional Fund Advisors LP 在第三季度将其在 Maximus 的持股增加了 2.0%。Dimensional Fund Advisors LP 目前拥有 1,869,573 股该健康服务提供商的股票，价值为 170,812,000 美元，此前在该期间又购买了 36,989 股。Geode Capital Management LLC 在第四季度将其在 Maximus 的持股增加了 0.3%。Geode Capital Management LLC 目前拥有 1,482,079 股该健康服务提供商的股票，价值为 127,952,000 美元，此前在该期间又购买了 5,130 股。Boston Partners 在第三季度将其在 Maximus 的持股增加了 47.0%。Boston Partners 目前拥有 966,139 股该健康服务提供商的股票，价值为 88,236,000 美元，此前在上个季度又购买了 308,892 股。Reinhart Partners LLC 在第三季度将其在 Maximus 的持股增加了 0.8%。Reinhart Partners LLC 目前拥有 921,578 股该健康服务提供商的股票，价值为 84,206,000 美元，此前在该期间又收购了 7,722 股。最后，Stephens Investment Management Group LLC 在第三季度将其在 Maximus 的持股增加了 49.0%。Stephens Investment Management Group LLC 目前拥有 720,943 股该健康服务提供商的股票，价值为 65,873,000 美元，此前在上个季度又收购了 237,097 股。机构投资者和对冲基金持有该公司 97.21% 的股票。</p>
<h2>Maximus 公司简介</h2>
<p>（获取免费报告）</p>
<p>Maximus, Inc.（纽约证券交易所代码：MMS）是一家全球政府服务提供商，专注于提供健康和人类服务项目。该公司与联邦、州和地方机构合作，管理和实施支持个人和家庭在不同生活阶段的项目。主要服务领域包括医疗补助、医疗保险、儿童健康保险计划（CHIP）及其他公共援助项目的资格认定和入学服务，以及呼叫中心运营、案件管理和项目完整性解决方案。</p>
<h2>了解更多</h2>
<ul>
<li>我们更看好的五只股票比 Maximus 更好</li>
<li>新法律：国会批准数字美元的设立？</li>
<li>你的银行账户不再安全</li>
<li>在 2026 年 5 月之前购买这只黄金股票</li>
<li>黄金市场崩溃的那一天</li>
<li>一位前 CIA 特工对即将到来的崩溃的看法</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/InsiderTradesChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU1NUw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/InsiderTradesChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU1NUw"/></p>
<p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或评论发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在 Maximus 吗？</h2>
<p>在考虑 Maximus 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其向客户推荐的股票。MarketBeat 已经识别出五只顶级分析师正在悄悄向客户推荐的股票，建议他们在更广泛的市场注意到之前立即购买……而 Maximus 并不在名单上。</p>
<p>尽管 Maximus 目前在分析师中获得了强烈买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

<p>Maximus 首席财务官 David Mutryn 以每股 75.62 美元的价格购买了 1,000 股公司股票，总计 75,620 美元。这次购买使他的持股比例增加了 2.56%，使他的总股份达到 40,037 股，估值约为 303 万美元。该股票最近的交易价格为 75.09 美元，市值为 41 亿美元。Maximus 报告每股收益为 1.85 美元，超出预期，并宣布每股股息增加至 0.33 美元，将于 3 月 2 日支付。分析师对该股票的评级不一，平均评级为 “强烈买入”</p>

<p>Maximus, Inc. (NYSE:MMS - Get Free Report) CFO David Mutryn purchased 1,000 shares of the stock in a transaction that occurred on Monday, February 9th. The stock was acquired at an average cost of $75.62 per share, for a total transaction of $75,620.00. Following the completion of the acquisition, the chief financial officer owned 40,037 shares in the company, valued at $3,027,597.94. This represents a 2.56% increase in their position. The purchase was disclosed in a filing with the SEC, which can be accessed through the SEC website.</p>
<div class="lb-trans"><p>Maximus, Inc.（纽约证券交易所代码：MMS - 获取免费报告）首席财务官 David Mutryn 于 2 月 9 日星期一购买了 1,000 股该股票。该股票的平均购买成本为每股 75.62 美元，总交易额为 75,620.00 美元。收购完成后，首席财务官在公司中持有 40,037 股，价值为 3,027,597.94 美元。这代表其持股增加了 2.56%。此次购买在向美国证券交易委员会（SEC）提交的文件中披露，相关信息可通过 SEC 网站访问。</p>
</div><h2>Maximus Price Performance</h2>
<div class="lb-trans"><h2>Maximus 价格表现</h2>
</div><p>Shares of MMS traded up $0.01 during midday trading on Monday, hitting $75.09. 1,168,871 shares of the company traded hands, compared to its average volume of 674,064. The stock has a market cap of $4.10 billion, a price-to-earnings ratio of 11.43 and a beta of 0.56. The firm has a 50 day moving average of $90.07 and a 200-day moving average of $86.58. The company has a debt-to-equity ratio of 0.88, a quick ratio of 2.34 and a current ratio of 2.34. Maximus, Inc. has a 52 week low of $63.77 and a 52 week high of $100.00.</p>
<div class="lb-trans"><p>在周一的午盘交易中，MMS 的股价上涨了 0.01 美元，达到了 75.09 美元。该公司交易了 1,168,871 股，而其平均交易量为 674,064 股。该股票的市值为 41 亿美元，市盈率为 11.43，贝塔值为 0.56。该公司 50 日移动平均线为 90.07 美元，200 日移动平均线为 86.58 美元。公司的债务与股本比率为 0.88，速动比率为 2.34，流动比率为 2.34。Maximus, Inc.的 52 周低点为 63.77 美元，52 周高点为 100.00 美元。</p>
</div><p>Maximus (NYSE:MMS - Get Free Report) last posted its earnings results on Thursday, February 5th. The health services provider reported $1.85 earnings per share for the quarter, beating analysts' consensus estimates of $1.84 by $0.01. Maximus had a net margin of 6.92% and a return on equity of 25.30%. The firm had revenue of $1.35 billion during the quarter, compared to analyst estimates of $1.37 billion. During the same period last year, the firm posted $1.61 earnings per share. Maximus's revenue for the quarter was down 4.1% compared to the same quarter last year. Maximus has set its FY 2026 guidance at 8.050-8.350 EPS. On average, analysts forecast that Maximus, Inc. will post 6.15 EPS for the current fiscal year.</p>
<div class="lb-trans"><p>Maximus（纽约证券交易所代码：MMS - 获取免费报告）最近一次发布财报是在 2 月 5 日星期四。这家健康服务提供商报告本季度每股收益为 1.85 美元，超出分析师一致预期的 1.84 美元，超出幅度为 0.01 美元。Maximus 的净利润率为 6.92%，股本回报率为 25.30%。该公司本季度的收入为 13.5 亿美元，而分析师预期为 13.7 亿美元。去年同期，该公司每股收益为 1.61 美元。与去年同期相比，Maximus 本季度的收入下降了 4.1%。Maximus 已将其 2026 财年的指引设定为每股收益 8.050-8.350 美元。分析师平均预测 Maximus, Inc.在当前财年将发布每股收益 6.15 美元。</p>
</div><h2>Maximus Increases Dividend</h2>
<div class="lb-trans"><h2>Maximus 增加股息</h2>
</div><p>The firm also recently disclosed a quarterly dividend, which will be paid on Monday, March 2nd. Shareholders of record on Friday, February 13th will be given a $0.33 dividend. This is a boost from Maximus's previous quarterly dividend of $0.30. The ex-dividend date of this dividend is Friday, February 13th. This represents a $1.32 annualized dividend and a yield of 1.8%. Maximus's dividend payout ratio is currently 18.26%.</p>
<div class="lb-trans"><p>该公司最近还披露了一项季度股息，将于 3 月 2 日星期一支付。2 月 13 日星期五的股东将获得 0.33 美元的股息。这比 Maximus 之前的季度股息 0.30 美元有所增加。该股息的除息日期为 2 月 13 日星期五。这代表每年 1.32 美元的股息，收益率为 1.8%。Maximus 的股息支付比率目前为 18.26%。</p>
</div><h2>Analyst Ratings Changes</h2>
<div class="lb-trans"><h2>分析师评级变动</h2>
</div><p>MMS has been the topic of a number of research reports. Zacks Research raised shares of Maximus from a &#34;hold&#34; rating to a &#34;strong-buy&#34; rating in a research report on Tuesday, December 30th. Wall Street Zen cut Maximus from a &#34;buy&#34; rating to a &#34;hold&#34; rating in a report on Saturday. Finally, Weiss Ratings reaffirmed a &#34;buy (b-)&#34; rating on shares of Maximus in a research note on Monday, December 29th. One equities research analyst has rated the stock with a Strong Buy rating and one has issued a Buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of &#34;Strong Buy&#34;.</p>
<div class="lb-trans"><p>MMS 成为多份研究报告的主题。Zacks Research 在 12 月 30 日星期二的研究报告中将 Maximus 的评级从 “持有” 上调至 “强力买入”。Wall Street Zen 在周六的报告中将 Maximus 的评级从 “买入” 下调至 “持有”。最后，Weiss Ratings 在 12 月 29 日星期一的研究报告中重申了对 Maximus 的 “买入（b-）” 评级。一位股票研究分析师对该股票给予了 “强力买入” 评级，另一位则给予了 “买入” 评级。根据 MarketBeat.com 的数据，该股票的平均评级为 “强力买入”。</p>
</div><p><strong>Read Our Latest Analysis on Maximus</strong></p>
<div class="lb-trans"><p><strong>阅读我们对 Maximus 的最新分析</strong></p>
</div><h2>Institutional Inflows and Outflows</h2>
<div class="lb-trans"><h2>机构资金流入和流出</h2>
</div><p>Hedge funds have recently bought and sold shares of the stock. Dimensional Fund Advisors LP increased its holdings in shares of Maximus by 2.0% in the third quarter. Dimensional Fund Advisors LP now owns 1,869,573 shares of the health services provider's stock valued at $170,812,000 after purchasing an additional 36,989 shares during the period. Geode Capital Management LLC increased its holdings in Maximus by 0.3% in the 4th quarter. Geode Capital Management LLC now owns 1,482,079 shares of the health services provider's stock worth $127,952,000 after buying an additional 5,130 shares during the period. Boston Partners raised its position in Maximus by 47.0% during the 3rd quarter. Boston Partners now owns 966,139 shares of the health services provider's stock worth $88,236,000 after buying an additional 308,892 shares during the last quarter. Reinhart Partners LLC. lifted its stake in Maximus by 0.8% during the 3rd quarter. Reinhart Partners LLC. now owns 921,578 shares of the health services provider's stock valued at $84,206,000 after acquiring an additional 7,722 shares during the period. Finally, Stephens Investment Management Group LLC boosted its holdings in shares of Maximus by 49.0% in the 3rd quarter. Stephens Investment Management Group LLC now owns 720,943 shares of the health services provider's stock valued at $65,873,000 after acquiring an additional 237,097 shares during the last quarter. Institutional investors and hedge funds own 97.21% of the company's stock.</p>
<div class="lb-trans"><p>对该股票的对冲基金最近进行了买卖。Dimensional Fund Advisors LP 在第三季度将其在 Maximus 的持股增加了 2.0%。Dimensional Fund Advisors LP 目前拥有 1,869,573 股该健康服务提供商的股票，价值为 170,812,000 美元，此前在该期间又购买了 36,989 股。Geode Capital Management LLC 在第四季度将其在 Maximus 的持股增加了 0.3%。Geode Capital Management LLC 目前拥有 1,482,079 股该健康服务提供商的股票，价值为 127,952,000 美元，此前在该期间又购买了 5,130 股。Boston Partners 在第三季度将其在 Maximus 的持股增加了 47.0%。Boston Partners 目前拥有 966,139 股该健康服务提供商的股票，价值为 88,236,000 美元，此前在上个季度又购买了 308,892 股。Reinhart Partners LLC 在第三季度将其在 Maximus 的持股增加了 0.8%。Reinhart Partners LLC 目前拥有 921,578 股该健康服务提供商的股票，价值为 84,206,000 美元，此前在该期间又收购了 7,722 股。最后，Stephens Investment Management Group LLC 在第三季度将其在 Maximus 的持股增加了 49.0%。Stephens Investment Management Group LLC 目前拥有 720,943 股该健康服务提供商的股票，价值为 65,873,000 美元，此前在上个季度又收购了 237,097 股。机构投资者和对冲基金持有该公司 97.21% 的股票。</p>
</div><h2>Maximus Company Profile</h2>
<div class="lb-trans"><h2>Maximus 公司简介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>Maximus, Inc NYSE: MMS is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children's Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.</p>
<div class="lb-trans"><p>Maximus, Inc.（纽约证券交易所代码：MMS）是一家全球政府服务提供商，专注于提供健康和人类服务项目。该公司与联邦、州和地方机构合作，管理和实施支持个人和家庭在不同生活阶段的项目。主要服务领域包括医疗补助、医疗保险、儿童健康保险计划（CHIP）及其他公共援助项目的资格认定和入学服务，以及呼叫中心运营、案件管理和项目完整性解决方案。</p>
</div><h2>Read More</h2>
<div class="lb-trans"><h2>了解更多</h2>
</div><ul>
<li>Five stocks we like better than Maximus</li>
<li>NEW LAW: Congress Approves Setup For Digital Dollar?</li>
<li>Your Bank Account Is No Longer Safe</li>
<li>Buy this Gold Stock Before May 2026</li>
<li>The day the gold market broke</li>
<li>What a Former CIA Agent Knows About the Coming Collapse</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票比 Maximus 更好</li>
<li>新法律：国会批准数字美元的设立？</li>
<li>你的银行账户不再安全</li>
<li>在 2026 年 5 月之前购买这只黄金股票</li>
<li>黄金市场崩溃的那一天</li>
<li>一位前 CIA 特工对即将到来的崩溃的看法</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/InsiderTradesChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU1NUw" alt="" original-src="https://www.marketbeat.com/scripts/InsiderTradesChart.ashx?Prefix=NYSE&amp;Symbol=MMS"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或评论发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Maximus Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 Maximus 吗？</h2>
</div><p>Before you consider Maximus, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 Maximus 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Maximus wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其向客户推荐的股票。MarketBeat 已经识别出五只顶级分析师正在悄悄向客户推荐的股票，建议他们在更广泛的市场注意到之前立即购买……而 Maximus 并不在名单上。</p>
</div><p>While Maximus currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>尽管 Maximus 目前在分析师中获得了强烈买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Maximus (NYSE:MMS) 的首席财务官购入了价值 75,620.00 美元的股票